{
    "Trade/Device Name(s)": [
        "ARKTM Gabapentin Assay",
        "ARKTM Gabapentin Calibrator",
        "ARKTM Gabapentin Control"
    ],
    "Submitter Information": "ARK Diagnostics, Inc.",
    "510(k) Number": "K101574",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OTF",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "November 15, 2010",
    "Summary Letter Received Date": "November 16, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3350"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin Test System"
    ],
    "Analyte Class(es)": [
        "tdm",
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Gabapentin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARK Gabapentin Assay system for quantitative measurement of gabapentin in serum or plasma using homogeneous enzyme immunoassay",
    "Indications for Use Summary": "Quantitative determination of gabapentin in human serum or plasma on automated clinical chemistry analyzers as an aid in management of patients treated with gabapentin",
    "fda_folder": "Toxicology"
}